HIGHLIGHTS
- who: Jia Li from the Department of Integrated Chinese and Western Medicine, The Affiliated Cancer Hospital of Zhengzhou University and Henan University, Shanghai, China have published the article: Outcomes of Anlotinib Maintenance Therapy in Patients With Advanced NSCLC in a Real-World Setting, in the Journal: (JOURNAL)
- what: The aims were: 1) to describe the demographic and clinical characteristics of patients receiving anlotinib maintenance Frontiers in Oncology | www.frontiersin.org This study showed a median PFS and OS of 11.5 and 12.0 months respectively in all patients, with 11.5 and 16.4 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.